NASDAQ
Guardant Health, Inc. (GH) has a price/sales ratio of 13.04x as of Friday, May 22, 2026. This represents a 19.23% increase compared to its 12-month average of 10.94x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.